Yunnan Botanee Bio-Technology Group Co.LTD

SZSE:300957 Stok Raporu

Piyasa değeri: CN¥22.0b

Yunnan Botanee Bio-Technology GroupLTD Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Yunnan Botanee Bio-Technology GroupLTD has been growing earnings at an average annual rate of 9.4%, while the Personal Products industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 20.9% per year. Yunnan Botanee Bio-Technology GroupLTD's return on equity is 9.9%, and it has net margins of 9.7%.

Anahtar bilgiler

9.4%

Kazanç büyüme oranı

6.5%

EPS büyüme oranı

Personal Products Sektör Büyümesi7.8%
Gelir büyüme oranı20.9%
Özkaynak getirisi9.9%
Net Marj9.7%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Nov 02
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Recent updates

Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Nov 02
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

Oct 19
Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Sep 27
The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Sep 25
Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

Jun 03
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

May 24
A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Feb 29
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Gelir ve Gider Dağılımı

Yunnan Botanee Bio-Technology GroupLTD nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:300957 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 246,1085923,535317
30 Jun 245,9597913,235304
31 Mar 245,7567753,145298
31 Dec 235,5227573,036299
30 Sep 235,5501,1132,712310
30 Jun 235,3321,1062,590282
31 Mar 235,0691,0642,424258
01 Jan 235,0141,0512,390255
30 Sep 224,8051,0252,353171
30 Jun 224,6609932,270152
31 Mar 224,3239302,107121
01 Jan 224,0228631,932113
30 Sep 213,3326831,62285
30 Jun 213,1076481,45082
31 Mar 212,8255681,37872
31 Dec 202,6365441,28163
31 Dec 191,94441298451
31 Dec 181,24026163243
31 Dec 1779815441528

Kaliteli Kazançlar: 300957 has a large one-off gain of CN¥186.1M impacting its last 12 months of financial results to 30th September, 2024.

Büyüyen Kar Marjı: 300957's current net profit margins (9.7%) are lower than last year (20.1%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 300957's earnings have grown by 9.4% per year over the past 5 years.

Büyüme Hızlandırma: 300957's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 300957 had negative earnings growth (-46.8%) over the past year, making it difficult to compare to the Personal Products industry average (-6%).


Özkaynak Getirisi

Yüksek ROE: 300957's Return on Equity (9.9%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin